Quantitative analysis of protein co-localization on B cells opsonized with rituximab and complement using the ImageStream multispectral imaging flow cytometer

Journal of Immunological Methods

Volumn 317, Issue 1-2, 2006, Pages 90-99

  Beum, Paul V ^a   Lindorfer, Margaret A ^a   Hall, Brian E ^b   George, Thaddeus C ^b   Frost, Keith ^b   Morrissey, Philip J ^b   Taylor, Ronald P ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b Amnis Corporation   (United States)

Author keywords

Complement; Multispectral imaging; Rituximab

Indexed keywords

COMPLEMENT COMPONENT C3B; FLUORESCENT DYE; IMMUNOGLOBULIN G; MALEIMIDE; MONOCLONAL ANTIBODY; PROTEIN; RITUXIMAB; THIOL DERIVATIVE;

ALGORITHM; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; DIGITAL IMAGING; DRUG DISTRIBUTION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMAGING SYSTEM; OPSONIZATION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; RAJI CELL; SERUM;

ALGORITHMS; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; B-LYMPHOCYTES; COMPLEMENT SYSTEM PROTEINS; DIAGNOSTIC IMAGING; FLOW CYTOMETRY; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; PROTEINS;

EID: 33751327802     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2006.09.012     Document Type: Article

References (15)

1. Arechiga A.F., Bell B.D., Solomon J.C., Chu I.H., Dubois C.L., Hall B.E., George T.C., Coder D.M., and Walsh C.M. FADD is not required for antigen receptor-mediated NF-κB activation. J. Immunol. 175 (2005) 7800
2. Cohen S.B., Greenwald M., Dougados M.R., Emery P., Furie R., Shaw T.M., and Totoritis M.C. Efficacy and safety of Rituximab in active RA patients who experienced an inadequate response to one or more anti-TNFα therapies (REFLEX study). Arthritis Rheum. 52 (2005) S677
3. Edwards J.C.W., Szczepanski L., Szechinski J., Filipowicz-Sosnowska A., Emery P., Close D.R., Stevens R.M., and Shaw T. Efficacy of B-cell-targeted therapy with Rituximab in patients with rheumatoid arthritis. N. Engl. J. Med. 350 (2004) 2572
4. George T.C., Basiji D.A., Hall B.E., Lynch D.H., Ortyn W.E., Perry D.J., Seo M.J., Zimmerman C.A., and Morrissey P.J. Distinguishing modes of cell death using the ImageStream multispectral imaging flow cytometer. Cytometry 59A (2004) 237
5. George T.C., Fanning S.L., Fitzgeral-Bocarsly P., Medeiros R.B., Highfill S., Shimizu Y., Hall B.E., Frost K., Basiji D., Ortyn W.E., Morrissey P.J., and Lynch D.H. Quantitative measurement of nuclear translocation events using similarity analysis of multispectral cellular images obtained in flow. J. Immunol. Methods 311 (2006) 117
6. Kennedy A.D., Solga M.D., Schuman T.A., Chi A.W., Lindorfer M.A., Sutherland W.M., Foley P.L., and Taylor R.P. An anti-C3b(i) mAb enhances complement activation, C3b(i) deposition, and killing of CD20+ cells by Rituximab. Blood 101 (2003) 1071
7. Kennedy A.D., Beum P.V., Solga M.D., DiLillo D.J., Lindorfer M.A., Hess C.E., Densmore J.J., Williams M.E., and Taylor R.P. Rituximab infusion promotes rapid complement depletion and acute CD20 loss in chronic lymphocytic leukemia. J. Immunol. 172 (2004) 3280
8. Maloney D.G. Preclinical and phase I and II trials of Rituximab. Semin. Oncol. 26 (1999) 74
9. McLaughlin P., Grillo-Lopez A.J., Link B.K., Levy R., Czuczman M.S., Williams M.E., Heyman M.R., Bence-Bruckler I., White C.A., Cabanillas F., Jain V., Ho A.D., Lister J., Wey K., Shen D., and Dallaire B.K. Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program. J. Clin. Oncol. 16 (1998) 2825
10. Ortyn W.E., Hall B.E., George T.C., Frost K., Basiji D.A., Perry D.J., Zimmerman C.A., Coder D., and Morrissey P.J. Sensitivity measurement and compensation in spectral imaging. Cytometry, Part A 69A (2006) 852
11. Serra J. Image Analysis and Mathematical Morphology (1982), Academic Press, London 34
12. Shohet J., Bergamaschini L., Davis A., and Caroll M. Localization of the human complement C3 binding site on the IgG heavy chain. J. Biol. Chem. 266 (1991) 18520
13. Shohet J.M., Pemberton P., and Carroll M.C. Identification of a major binding site for complement C3 on the IgG1 heavy chain. J. Biol. Chem. 268 (1993) 5866
14. Tosic L., Sutherland W.M., Kurek J., Edberg J.C., and Taylor R.P. Preparation of monoclonal antibodies to C3b by immunization with C3b(i)-sepharose. J. Immunol. Methods 120 (1989) 241
15. Walport M.J. Complement. N. Engl. J. Med. 344 (2001) 1058